Reimbursement Landscape Assessment2021-05-21T12:52:53-04:00

Reimbursement Landscape Assessment

  • Success in the marketplace depends on developing (and executing) a systematic reimbursement and market access strategy as early as possible.

  • Knowing whether to go for a national coverage (NCD), regional Medicare Administrative Contractors (MACs), or a payer roadshow (and which ones to approach first) is a multi-faceted decision pathway based on type of product, the ability of the available evidence to meet payer-specific thresholds, and the quantity of specific types of evidence, among many other factors.

  • Different reimbursement pathways carry different levels of risk and cost; having a plan informed by reimbursement experts and payer intelligence is a critical part of a market access plan.

  • Regulatory approval nor coding by itself guarantees reimbursement. Reimbursement is a 3-legged stool: coding, coverage, and payment. Payers make coverage and payment determinations through Health Technology Assessments (HTA) – and in the US, there is no universally set standard for HTA; every payer has their own process.

  • Support from key opinion leaders (KOLs) is instrumental to reimbursement.

  • Alternative pricing and payment models are taking off. As payers update their policies each year, there continues to be more and more transition from the traditional fee-for-service model to a value-based system.

  • If you’re unfamiliar with the US healthcare reimbursement system, our experts can provide you with a reimbursement landscape – a high-level overview of reimbursement (coding, coverage and payment) in the US – explaining how it pertains to your product and the need for all elements to come together for consistent reimbursement.

  • If you’re already familiar with the reimbursement system(s) within your target marketplace(s) and would like to understand how your product fits into the general landscape, our experts can conduct a reimbursement review with considerations for future reimbursement.

  • If you require support in developing a successful reimbursement strategy, our experts can conduct reimbursement assessments or review findings from existing assessments and build and convene payer advisory boards (comprised of current and former medical policy influencers and decision-makers) to develop or assess and validate your strategy, helping to identify appropriate sources of coverage, define the elements of reimbursement (coding, coverage and payment) as well as potential reimbursement pathways, and refine payer implementation timelines for your technology. We’ll detail specific actions and data elements required to obtain reimbursement of your technology as it pertains to its indicated use, identifying any data gaps in planned, ongoing or previous studies to ensure a winning reimbursement strategy with the best possible data package for your technology in order to support payer coverage and market access.


Related Solutions

Gavel & stethoscope in front of medical and law books.

Policy Research & Monitoring

Medtech competitive analysis results being reviewed by a health economics and market access expert.

Competitive Analysis

Stethoscope sitting on medical insurance reimbursement documents.

Payer Engagement

Obtain Favorable Reimbursement

Purposeful payer, pricing, and reimbursement strategies carefully aligned with value frameworks and evidence requirements are critical in optimizing your speed to market and your product’s overall commercialization success. Contact our experts for reimbursement strategy and support.

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.
Go to Top